» Articles » PMID: 6417538

Immunoglobulin-gene Rearrangements As Unique Clonal Markers in Human Lymphoid Neoplasms

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1983 Dec 29
PMID 6417538
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Immunoglobulin genes in their germ-line form are separated DNA subsegments that must be joined by means of recombinations during B-cell development. Individual immunoglobulin-gene rearrangements are specific for a given B cell and its progeny. We show that the detection of such gene rearrangements by Southern hybridization provides a sensitive marker for both clonality and B-cell lineage within lymphoid tissues lacking expression of definitive surface phenotypes. We have used these genetic markers in three ways: to establish a diagnosis of lymphoma in a neoplastic disorder of uncertain cell type, to show that some lymphomas that were previously classified as being of T-cell type in fact contain monoclonal B cells, and to detect clonal B-cell populations within lymphomatous tissues of uncertain immunotype and within an atypical lymphofollicular hyperplasia having no other clonal surface markers. These sensitive and unique indicators of clonality located directly at the DNA level are capable of providing insights into the cellular origin, early detection, and natural history of neoplasia.

Citing Articles

Prognostic relevance of immunoglobulin heavy chain rearrangement and immunoglobulin kappa light chain rearrangement in patients with diffuse large B cell lymphoma.

Wang J, Zhao S, Niu T, Chen J, Li H, Xiong H Oncologist. 2025; 30(3).

PMID: 40063611 PMC: 11892554. DOI: 10.1093/oncolo/oyaf016.


Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in diffuse large B-cell lymphoma: a multicenter retrospective study.

Kim Y, Shin H, Yhim H, Yang D, Park Y, Lee J Front Oncol. 2024; 14:1363385.

PMID: 38410112 PMC: 10894990. DOI: 10.3389/fonc.2024.1363385.


Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma.

Zhao K, Zheng X, Liu X, Liu T, Ke Z, Zhu F Oncologist. 2024; 29(5):e672-e680.

PMID: 38297976 PMC: 11067791. DOI: 10.1093/oncolo/oyae008.


Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas.

Shukla N, Schroers-Martin J, Sworder B, Kathuria K, Alig S, Frank M Blood Adv. 2023; 8(3):780-784.

PMID: 38147627 PMC: 10847740. DOI: 10.1182/bloodadvances.2023011997.


Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.

Petrova-Drus K, Syed M, Yu W, Hutt K, Zlotnicki A, Huang Y J Mol Diagn. 2023; 25(6):352-366.

PMID: 36963483 PMC: 10243287. DOI: 10.1016/j.jmoldx.2023.02.005.